ALFA Filings
Every announcement, straight from the exchange
Every Bliss GVS Pharma annual general meeting announcement on NSE and BSE, newest first, each with its own page.
Time
7 announcements
Bliss GVS Pharma has issued a postal ballot notice to seek member approval for the appointment of three directors. This follows a recent change in control.
Bliss GVS Pharma Ltd reported the voting results of its postal ballot. Members approved the appointment of Mr. Santosh Parab as a Non-Executive and Non-Independent Director.
Bliss GVS Pharma Ltd issued a Postal Ballot Notice to seek shareholder approval for the appointment of Mr. Santosh Parab as a Director.
Bliss GVS Pharma concluded its 41st AGM on July 15, 2026. Shareholders approved a 100% final dividend of Re. 1.00 per share for FY 2025-26.
Bliss GVS Pharma announced successful postal ballot results for appointing two independent directors. Shareholders approved both special resolutions with overwhelming majorities via remote electronic voting.
Bliss GVS Pharma Limited has issued a Postal Ballot notice seeking shareholder approval for the appointment of Mr. Vijayanarayanan Mahadevan and Mr. Deepak Rameshchandra Shah as Independent Directors. Both appointments are for a five-year term effective from April 03, 2026. The e-voting period ends on May 09, 2026.
Bliss GVS Pharma Limited has issued a Postal Ballot Notice to seek shareholder approval for the appointment of Mr. Vijayanarayanan Mahadevan and Mr. Deepak Rameshchandra Shah as Independent Directors for five-year terms. The e-voting period runs from April 10, 2026, to May 09, 2026, with results to be announced by May 12, 2026.